Acquisition of Assets (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Asset Acquisition [Line Items]
Research and development		$ 311,681	$ 44,966	$ 32,788
POINT Biopharma
Asset Acquisition [Line Items]
Payment for acquisitions	$ 260,000
Asset acquisition, additional milestone payments	1,800,000
Research and development		$ 260,000
PNT2002 License Agreement
Asset Acquisition [Line Items]
Payment for acquisitions	$ 250,000
Royalty percentage	20.00%
PNT2002 License Agreement | Regulatory Milestones
Asset Acquisition [Line Items]
Asset acquisition, additional milestone payments	$ 281,000
PNT2002 License Agreement | Sales Milestones
Asset Acquisition [Line Items]
Asset acquisition, additional milestone payments	1,300,000
PNT2003 License Agreement
Asset Acquisition [Line Items]
Payment for acquisitions	$ 10,000
Royalty percentage	15.00%
PNT2003 License Agreement | Regulatory Milestones
Asset Acquisition [Line Items]
Asset acquisition, additional milestone payments	$ 34,500
PNT2003 License Agreement | Sales Milestones
Asset Acquisition [Line Items]
Asset acquisition, additional milestone payments	$ 275,000